Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Abbott achieves 2008 financial goals

Abbott achieves 2008 financial goals

27th April 2009

Abbott delivered on its financial goals last year, it has asserted.

During 2008, the company’s ongoing earnings grew by double figures and it saw the 36th consecutive yearly increase in cash dividend, which rose by 11 per cent.

The firm also introduced a number of new products, including cholesterol management drug Trilipix and Humira to aid rheumatoid arthritis.

Miles D White, Abbott’s chairman and chief executive officer, remarked the company had met its strategic, operational and fiscal targets.

“Our company remains strong, focused and ready for the future,” he said.

“The steps we’ve taken in recent years to strengthen our company with a diverse mix of businesses stand us in very good stead for these times.”

Partly due to financial strength, the company is in a good position to take advantage of opportunities and to develop in the long-term, Mr White concluded.

Last week, Abbott released its first quarter of 2009 results and worldwide pharmaceutical sales had increased 0.9 per cent compared to the same period in 2008.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.